suPERficial Slow-flow Vascular malFORMations Treated With sirolimUS
NCT02509468
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
63
Enrollment
OTHER
Sponsor class
Conditions
Vascular Malformation
Interventions
DRUG:
Sirolimus
Sponsor
University Hospital, Tours